[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
SEC Filings Digest @USCorpFilings on x 4400 followers
Created: 2025-07-21 12:00:07 UTC
$SABS Equity Investments:
On July 21, 2025, SAB Biotherapeutics, Inc. entered into a securities purchase agreement to issue and sell XXXXXXXXX shares of Series B Preferred Stock and warrants, aiming to raise approximately $XXX million for its Phase 2b SAFEGUARD study and general purposes. The Preferred Stock will convert into common stock at $XXXX per share, subject to stockholder approval.
XXX engagements
Related Topics seed funding stocks $sabs sec